Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Napabucasin + FOLFIRI vs Napabucasin in Metastatic CRC
NCT03522649Phase 3Unknown
- Sponsor
- 1Globe Health Institute
- Start
- Apr 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of napabucasin in metastatic colorectal cancer (mCRC), sponsored by 1Globe Health Institute. Status: unknown.
02
Drugs
napabucasin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03522649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522649.